InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
bme Free
05/02/23 5:45 PM
profile icon
bme Free
05/02/23 3:54 PM
profile icon
trader59 PremiumMember
05/02/23 2:55 PM
profile icon
bme Free
05/02/23 2:43 PM
profile icon
trader59 PremiumMember
04/19/23 4:23 PM
profile icon
bme Free
04/19/23 12:01 PM
profile icon
trader59 PremiumMember
04/18/23 7:45 PM
profile icon
bme Free
04/18/23 7:17 PM
profile icon
tdbowieknife PremiumMember
04/12/23 11:49 AM
profile icon
trader59 PremiumMember
04/12/23 11:22 AM
profile icon
tdbowieknife PremiumMember
04/12/23 10:43 AM
profile icon
Renee PremiumMember
04/12/23 12:55 AM
profile icon
trader59 PremiumMember
04/11/23 7:37 PM
profile icon
Renee PremiumMember
04/11/23 5:15 PM
profile icon
willlbone Free
04/11/23 1:15 PM
profile icon
Renee PremiumMember
12/27/22 5:12 PM
profile icon
bme Free
12/27/22 5:06 PM
profile icon
Renee PremiumMember
12/22/22 6:33 PM
profile icon
trendzone Free
12/20/22 4:39 AM
profile icon
joe botts Free
12/19/22 4:58 PM
profile icon
trendzone Free
12/19/22 4:06 PM
profile icon
joe botts Free
12/19/22 3:30 PM
profile icon
Sadie115 Free
12/07/22 6:09 AM
profile icon
Sadie115 Free
12/07/22 6:06 AM
profile icon
joe botts Free
12/05/22 9:20 PM
profile icon
DK11 Free
12/05/22 8:45 PM
profile icon
joe botts Free
12/05/22 5:42 PM
profile icon
joe botts Free
12/05/22 5:23 PM
profile icon
DK11 Free
12/05/22 3:47 PM
profile icon
joe botts Free
12/05/22 3:20 PM
profile icon
DK11 Free
12/02/22 9:03 PM
profile icon
DK11 Free
12/02/22 8:54 PM
profile icon
DK11 Free
12/02/22 2:32 PM
profile icon
Imokhopeur Free
12/02/22 10:12 AM
profile icon
DK11 Free
12/01/22 4:42 PM
profile icon
INFINITI Free
12/01/22 8:03 AM
profile icon
jimtash Free
12/01/22 8:02 AM
Bullish
Bullish
profile icon
jimtash Free
12/01/22 7:32 AM
profile icon
INFINITI Free
12/01/22 7:19 AM
profile icon
jimtash Free
12/01/22 7:16 AM
profile icon
jimtash Free
11/30/22 10:43 PM
profile icon
Mojocash PremiumMember
11/30/22 10:27 PM
profile icon
Mojocash PremiumMember
11/30/22 10:22 PM
profile icon
jimtash Free
11/30/22 8:01 PM
Bullish
Bullish
profile icon
Mojocash PremiumMember
11/30/22 4:30 PM
profile icon
TheFinalCD PremiumMember
11/30/22 4:28 PM

Otonomy Inc. fka OTIC RSS Feed

Followers
28
Posters
106
Posts (Today)
0
Posts (Total)
549
Created
12/27/14
Type
Free
Moderators
Otonomy, Inc (OTIC) 
 
 
Company website
 

 
Company Address:
6275 Nancy Ridge Drive
Suite 100
San Diego, CA 92121
United States - Map
Phone: 858-242-5200
Fax: 858-200-0933

 
Otonomy, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of diseases and disorders of the ear. To overcome many of the limitations of delivering drugs to the middle and inner ear, we have developed a proprietary technology that is designed to deliver drug that is retained in the ear for an extended period of time following a single local administration, which we refer to as “sustained-exposure.” Utilizing this technology, we have advanced three product candidates into development: AuriPro, OTO-104 and OTO-311. Our lead product candidate, AuriPro, is a sustained-exposure antibiotic that has completed two identical Phase 3 clinical trials in a total of 532 pediatric patients with middle ear effusion at the time of tympanostomy tube placement surgery. Top-line results of these Phase 3 trials demonstrated that AuriPro achieved the primary efficacy endpoint with statistical significance (p<0.001) and was well tolerated. Our second product candidate, OTO-104, is a sustained-exposure steroid in a Phase 2b clinical trial for patients with Ménière’s disease. Our third product candidate, OTO-311, is in preclinical development as a treatment for tinnitus. There are no drugs approved by the FDA for the lead indications we are currently pursuing for our product candidates.
 
Management
 
Pipeline
 
Yahoo Headlines
 
Seeking Alpha
 
Press Releases
 
SEC Filings
 
Share Structure:  See SEC filings
 
Investor Relations:  ir@otonomy.com
 
 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp